Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice:: Role of CRF receptor subtypes 1 and 2

被引:157
作者
Martínez, V
Wang, LX
Rivier, JE
Vale, W
Taché, Y
机构
[1] Univ Calif Los Angeles, Dept Med, Div Digest Dis, VA Greater Los Angeles Healthcare Syst,CURE,DDRC, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90073 USA
[3] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1124/jpet.301.2.611
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peripheral CRF inhibits gastric emptying and stimulates colonic motor function in rats. We investigated the role of CRF1 and CRF2 receptors in i.p. CRF-induced alterations of gut transit in conscious mice using selective CRF1 and CRF2 ligands injected i.p. Gastric emptying 2 h after ingestion of a solid chow meal and colonic transit (time to expel a bead inserted into the distal colon) were determined simultaneously. Rat/human (r/h)CRF, which has CRF1 > CRF2 binding affinity, decreased distal colonic transit time at lower doses (6-12 mug/kg) than those inhibiting gastric emptying (20-60 mug/kg). Ovine CRF, a preferential CRF1 receptor agonist (6-60 mug/kg), reduced significantly the colonic transit time without altering gastric emptying, whereas the selective CRF2 receptor agonists mouse urocortin II (20-60 mug/kg) and urocortin III (120 mug/kg) inhibited significantly gastric emptying without modifying colonic transit. The CRF1/CRF2 receptor antagonist, astressin (30-120 mug/kg), dose dependently prevented r/hCRF (20 mug/kg)-induced inhibition of gastric emptying and reduction of colonic transit time. The selective CRF1 receptor antagonists, NBI-27914 (C18H20Cl4N4C7H8O3S) and CP-154,526 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethylamine) (5-30 mg/kg), dose dependently blocked r/hCRF action on the colon without influencing the gastric response, whereas the CRF2 receptor antagonist, antisauvagine-30 (30-100 mug/kg), dose dependently abolished r/hCRF-induced delayed gastric emptying and had no effect on colonic response. These data show that i.p. r/hCRF-induced opposite actions on upper and lower gut transit in conscious mice are mediated by different CRF receptor subtypes: the activation of CRF1 receptors stimulates colonic propulsive activity, whereas activation of CRF2 receptors inhibits gastric emptying.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 44 条
  • [1] Urocrotin reduces food intake and gastric emptying in lean and ob/ob obese mice
    Asakawa, A
    Inui, A
    Ueno, N
    Makino, S
    Fujino, MA
    Kasuga, W
    [J]. GASTROENTEROLOGY, 1999, 116 (06) : 1287 - 1292
  • [2] mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues
    Baigent, SM
    Lowry, PJ
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) : 43 - 52
  • [3] Leptin-induced decrease in food intake is not associated with changes in gastric emptying in lean mice
    Barrachina, MD
    Martinez, V
    Wei, JY
    Tache, Y
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (03) : R1007 - R1011
  • [4] Behan DP, 1996, MOL PSYCHIATR, V1, P265
  • [5] Pharmacological and chemical properties of astressin, antisauvagine-30 and α-helCRF:: significance for behavioral experiments
    Brauns, O
    Liepold, T
    Radulovic, J
    Spiess, J
    [J]. NEUROPHARMACOLOGY, 2001, 41 (04) : 507 - 516
  • [6] Chen C, 1996, J MED CHEM, V39, P4358
  • [7] Cloning and characterization of human urocortin
    Donaldson, CJ
    Sutton, SW
    Perrin, MH
    Corrigan, AZ
    Lewis, KA
    Rivier, JE
    Vaughan, JM
    Vale, WW
    [J]. ENDOCRINOLOGY, 1996, 137 (05) : 2167 - 2170
  • [8] A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: Implications for the design of agonists and antagonists
    Eckart, K
    Jahn, O
    Radulovic, J
    Tezval, H
    van Werven, L
    Spiess, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) : 11142 - 11147
  • [9] Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome
    Fukudo, S
    Nomura, T
    Hongo, M
    [J]. GUT, 1998, 42 (06) : 845 - 849
  • [10] POTENT, STRUCTURALLY CONSTRAINED AGONISTS AND COMPETITIVE ANTAGONISTS OF CORTICOTROPIN-RELEASING FACTOR
    GULYAS, J
    RIVIER, C
    PERRIN, M
    KOERBER, SC
    SUTTON, S
    CORRIGAN, A
    LAHRICHI, SL
    CRAIG, AG
    VALE, W
    RIVIER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10575 - 10579